Results     05-May-23
Announcements
Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
Sales decline 0.66% to Rs 1406.45 crore
Net profit of Alembic Pharmaceuticals rose 596.17% to Rs 152.60 crore in the quarter ended March 2023 as against Rs 21.92 crore during the previous quarter ended March 2022. Sales declined 0.66% to Rs 1406.45 crore in the quarter ended March 2023 as against Rs 1415.74 crore during the previous quarter ended March 2022.

For the full year,net profit declined 34.35% to Rs 341.98 crore in the year ended March 2023 as against Rs 520.94 crore during the previous year ended March 2022. Sales rose 6.54% to Rs 5652.62 crore in the year ended March 2023 as against Rs 5305.79 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales1406.451415.74 -1 5652.625305.79 7
OPM %14.4910.47 -11.9816.48 -
PBDT190.29151.74 25 630.02912.17 -31
PBT116.1728.66 305 354.59625.39 -43
NP152.6021.92 596 341.98520.94 -34

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 16.78% in the March 2024 quarter
 ( Results - Announcements 09-May-24   15:06 )
  Volumes soar at Jubilant Pharmova Ltd counter
 ( Hot Pursuit - 09-Sep-24   14:30 )
  Alembic Pharmaceuticals receives USFDA approval for Sacubitril and Valsartan Tablets
 ( Corporate News - 30-May-24   14:49 )
  Alembic Pharma gains after receiving USFDA nod for Betamethasone Valerate Foam
 ( Hot Pursuit - 26-Aug-24   09:55 )
  Alembic Pharma hits record high on USFDA nod for anti psychotic drug
 ( Hot Pursuit - 24-Jul-24   14:43 )
  Alembic Pharma gets US FDA nod for heart failure-treatment drug
 ( Hot Pursuit - 30-May-24   14:05 )
  Board of Alembic Pharmaceuticals recommends final dividend
 ( Corporate News - 09-May-24   14:56 )
  Alembic Pharma gets USFDA nod for Icatibant injection
 ( Hot Pursuit - 17-Jun-24   14:03 )
  Alembic Pharmaceuticals receives EIR for its Injectable Facility at Karkhadi
 ( Corporate News - 16-Feb-23   15:25 )
  Alembic Pharmaceuticals receives EIR for its oncology unit at Panelav
 ( Corporate News - 06-May-24   08:52 )
  Alembic Pharmaceuticals receives USFDA approval for Glycopyrrolate Injection
 ( Corporate News - 01-Nov-22   11:41 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top